Skip to main content
. 2018 Aug 30;8(8):e023605. doi: 10.1136/bmjopen-2018-023605

Figure 1.

Figure 1

Percent of drugs approved through different pathways. Grey—percent with Notice of Compliance with conditions; orange—percent with priority review; blue—percent with standard review.